PharmaEssentia (TPE:6446) Cyclically Adjusted Book per Share: NT$34.39 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6446 PharmaEssentia Corp TPE:6446
76 GF Score
Price NT$1,375.00
GF Value NT$1,076.77
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is PharmaEssentia Cyclically Adjusted Book per Share?

PharmaEssentia TPE:6446 -1.79% 76 Cyclically Adjusted Book per Share is NT$34.39 as of Jun. 2026. GuruFocus rates TPE:6446 with a GF Score™ of 76/100 and a GF Value™ of NT$1,076.77 (Modestly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

PharmaEssentia's adjusted book value per share for the three months ended in Jun. 2026 was NT$88.835. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$34.39 for the trailing ten years ended in Jun. 2026.

During the past 12 months, PharmaEssentia's average Cyclically Adjusted Book Growth Rate was 30.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-21), PharmaEssentia's current stock price is NT$1375.00. PharmaEssentia's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was NT$34.39. PharmaEssentia's Cyclically Adjusted PB Ratio of today is 39.98.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of PharmaEssentia was 43.62. The lowest was 12.50. And the median was 19.60.


PharmaEssentia  (TPE:6446) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

PharmaEssentia's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1375.00/34.39
=39.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of PharmaEssentia was 43.62. The lowest was 12.50. And the median was 19.60.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


PharmaEssentia Cyclically Adjusted Book per Share Related Terms


PharmaEssentia Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for PharmaEssentia's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaEssentia Cyclically Adjusted Book per Share Chart

PharmaEssentia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 16.80 23.05 29.52

PharmaEssentia Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.40 27.74 29.52 31.98 34.39

TPE:6446 vs ZTS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PharmaEssentia's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaEssentia Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PharmaEssentia's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where PharmaEssentia's Cyclically Adjusted PB Ratio falls into.


TPE:6446
76GF Score
PharmaEssentia Corp TPE:6446
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PharmaEssentia Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PharmaEssentia's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=88.835/333.9520*333.9520
=88.835

Current CPI (Jun. 2026) = 333.9520.

PharmaEssentia Quarterly Data

Book Value per Share CPI Adj_Book
201609 16.202 241.428 22.411
201612 15.439 241.432 21.355
201703 14.803 243.801 20.277
201706 14.014 244.955 19.106
201709 13.337 246.819 18.045
201712 12.485 246.524 16.913
201803 11.745 249.554 15.717
201806 10.950 251.989 14.512
201809 10.164 252.439 13.446
201812 8.911 251.233 11.845
201903 8.054 254.202 10.581
201906 7.459 256.143 9.725
201909 6.608 256.759 8.595
201912 7.914 256.974 10.285
202003 6.979 258.115 9.030
202006 10.950 257.797 14.185
202009 15.234 260.280 19.546
202012 12.071 260.474 15.476
202103 9.742 264.877 12.283
202106 8.081 271.696 9.933
202109 5.957 274.310 7.252
202112 12.487 278.802 14.957
202203 11.658 287.504 13.541
202206 15.856 296.311 17.870
202209 15.463 296.808 17.398
202212 32.707 296.797 36.801
202303 32.416 301.836 35.865
202306 60.950 305.109 66.712
202309 58.560 307.789 63.538
202312 58.710 306.746 63.917
202403 59.752 312.332 63.888
202406 61.951 314.175 65.851
202409 63.768 315.301 67.540
202412 69.185 315.605 73.207
202503 71.036 319.799 74.180
202506 69.581 322.561 72.038
202509 72.512 324.800 74.555
202512 77.663 324.054 80.035
202603 83.515 330.213 84.461
202606 88.835 333.952 88.835

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of NT$34.39 mean?
PharmaEssentia (TPE:6446) has a Cyclically Adjusted Book per Share of NT$34.39 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on PharmaEssentia and its competitors.
Is PharmaEssentia's Cyclically Adjusted Book per Share too high?
PharmaEssentia's current Cyclically Adjusted Book per Share is NT$34.39. Overall, PharmaEssentia has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PharmaEssentia's Cyclically Adjusted Book per Share compare to ZTS?
PharmaEssentia's Cyclically Adjusted Book per Share of NT$34.39 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on PharmaEssentia and its competitors. PharmaEssentia's current Cyclically Adjusted Book per Share is NT$34.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaEssentia stock overvalued right now?
Based on GuruFocus' analysis, PharmaEssentia (TPE:6446) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$1,076.77, compared to a current price of NT$1,375.00 — trading 27.7% above its estimated fair value. The current Cyclically Adjusted Book per Share is NT$34.39. PharmaEssentia's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For PharmaEssentia (TPE:6446), the current Cyclically Adjusted Book per Share is NT$34.39 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PharmaEssentia (TPE:6446) Overvalued in 2026?

Based on GuruFocus' analysis, PharmaEssentia stock appears to be overvalued. The current stock price of NT$1,375.00 is trading 27.7% above its estimated GF Value™ of NT$1,076.77. GuruFocus considers PharmaEssentia to be Modestly Overvalued.

Key valuation signals for TPE:6446:

  • Cyclically Adjusted Book per Share: NT$34.39
  • GF Value™: NT$1,076.77 vs. price of NT$1,375.00 (27.7% above fair value)
  • GF Score™: 76/100 with 4 warning signs

No single metric tells the full story. See the TPE:6446 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PharmaEssentia Business Description

Address 13th Floor, No.3, Park Street, Nangang District, Taipei, TWN, 115
PharmaEssentia Corp engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API and new drug patterns developments. Its products include BESREMi, Ropeginterferon alfa-2b, Ropeg + anti PD-1, PEG-IL-2, PEG-Cytokines, PD-1-IL-2v, NY-ESO-1 TCR-T, among others. It derives revenue from medicine products sales from contracts with customers.
76GF Score

Get the complete analysis for TPE:6446

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$1,375.00
Price
NT$1,076.77
GF Value